Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-004438)

Filing Details

Accession Number:: 0001209191-23-004438
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-23 17:02:40
Reporting Period:: 2023-01-23

Accepted Time:: 2023-01-23 17:02:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Albireo Pharma Inc.	ALBO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1213040	J. Martha Carter	C/O Albireo Pharma, Inc. 53 State Street, 19Th Floor Boston MA 02109	Chief Regulatory Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-23	120	$43.80	14,506	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 3,656 shares of common stock and 10,850 restricted stock units.